HOME >> MEDICINE >> NEWS
Toward the future of cancer prevention

want to control the process of cancer development with drugs and supplements."

Hong launched the first chemoprevention clinical trial of its kind when he and a team of researchers demonstrated that smoking impaired the ability of vitamin A and its chemical cousin, retinoids, to keep cells healthy. In the early 1990s, they demonstrated that daily doses of retinoids could stop precancerous growths in the mouth and oral cavity from turning into cancer. They proved, for the first time, that cancer could be reversed. That work has led to examining other formulas of retinoic acids and other, unrelated agents.

Current strategies of "chemoprevention" - the use of natural or synthetic substances to reduce the risk of developing cancer - are less geared toward preventing all cancer than toward preventing specific major cancers, Lippman says.

"Great clinical strides have been made in breast, colorectal and prostate cancer prevention," Lippman says. For example, he says that tamoxifen (Nolvadex) reduced breast cancer risk by 50 percent in the Breast Cancer Prevention Trial, and finasteride (Propecia, Proscar) reduced prostate cancer risk by 25 percent in the Prostate Cancer Prevention Trial.

But men and women haven't flocked to get prescriptions for either agent because, as Lippman points out, these two large-scale trials indicated that some serious side effects came along with preventive benefits. "This stand-off between agent risks and benefits has raised a major focus of cancer prevention - tailoring interventions to specific groups of people.

"Efforts to identify people at a very high cancer risk and likely to benefit from and not be harmed by particular agents will be crucial to the future of cancer prevention," Lippman says. He leads an effort at M. D. Anderson and several other cancer centers to understand prostate cancer risk and how finasteride changed this risk in the Prostate Cancer Prevention Tr
'"/>

Contact: Nancy Jensen
nwjensen@mdanderson.org
713-794-1584
University of Texas M. D. Anderson Cancer Center
16-Dec-2005


Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine news :

1. NIH scientists target future pandemic strains of H5N1 avian influenza
2. The Eli and Edythe Broad Foundation invests in gastroenterologys future
3. The future of biofuels is not in corn
4. The future of biofuels is not in corn
5. Inactive kids storing up illness for the future
6. SCAIs Therapies in Evolution showcases exciting future of interventional cardiology
7. Conception date affects babys future academic achievement
8. ASU, Walter Reed researchers create prosthesis of the future
9. Why GNEP cant jump to the future
10. NeuroArm: Navigating the future of surgery
11. IceSAR campaign provides glimpse of future Sentinel-1 images over ice

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/26/2017)... (PRWEB) , ... February 26, ... ... sets a new technology standard in staffing, scheduling, and reporting for healthcare ... and predict activity throughout the entire staffing process. StaffBridge technology improves staffing ...
(Date:2/26/2017)... , ... February 26, 2017 , ... ... after receiving cognitive rehabilitation, according to a study released today at the 1st ... cognitive rehabilitation programs are proven to be effective in improving cognitive function in ...
(Date:2/25/2017)... (PRWEB) , ... February 25, 2017 , ... FCPX users ... Color tools from Pixel Film Studios. With ProSharpen Color users have total control over ... easily refine their color range. With color spectrum tools users can visually see the ...
(Date:2/24/2017)... ... February 24, 2017 , ... Houston ... options at his office, Antoine Dental Center. Currently, patients can get single dental ... may apply, but patients can learn more about these offers by contacting Antoine ...
(Date:2/24/2017)... , ... February 24, 2017 , ... ... business development, education, networking and recognition opportunities as well as advocacy for the ... in Holmdel, NJ on February 23. The Council's Innovation Forecast event highlights ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... TAMPA, Fla. , Feb. 27, 2017 /PRNewswire/ ... company focused on developing cerebral embolic protection devices ... of the FDA,s Circulatory System Devices Panel that ... the need for cerebral protection following transcatheter aortic ... shared by this FDA panel support the need ...
(Date:2/27/2017)... Feb. 27, 2017  Impax Laboratories, Inc. (NASDAQ: IPXL ) today ... Raymond James and Associates, 38 th ... 2017 in Orlando, FL. Cowen ... ET on March 7, 2017 in Boston, MA. ... 16, 2017 in Miami, FL. ...
(Date:2/27/2017)... BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced ... President and Chief Executive Officer (CEO) and member of the ... Richard Love , interim President and CEO who will ... Craig has over 20 years of experience in hematology, oncology ... Europe . "On behalf of CTI BioPharma,s ...
Breaking Medicine Technology:
Cached News: